Just when it thought that it could
see the end of its Deepwater Horizon
oil spill woes, Texas City has come
back to haunt energy major BP.
A UN report on biodiversity loss makes a compelling economic case for businesses
to be more proactive in preserving the natural environment, reports Cath O’Driscoll
Is uncorking headed for the dustbin?
The webinar begins by asking the question “Why is the Earth’s surface the temperature it is?”.
With the ever increasing change in the global economic demographics it is time to consider just what impact this has beyond the already accepted increase in healthcare costs.
There are no postcards for the issue of C&I Magazine which you have selected.
Click here to see other postcards from our international correspondents.
Biodiversity is a major issue that industries, like the
pharmaceutical sector, can only ignore at their peril. As
C&I reports in this issue, the loss of biodiversity could
cost the Earth
In a series of papers, the latest of which is J. Am.
Chem. Soc., 2010, 132, 9289, Ball has made it
possible to complex dirhodium complexes with
carboxylic acid side-chains on peptides, for
example, those from aspartic acid residues (D).
The discovery of chemical isotopes
in 1911 by the English physical
chemist Frederick Soddy set
alarm bells ringing throughout
the chemical community.
The hype manufactured by Craig Venter around the creation
of synthetic life does the field a disservice, says David Leak
Sanofi-aventis and Merck have
appointed Raul Kohan ceo of their
joint animal health venture Merial-